The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sunitinib Bluefish 25 mg hard capsules



Bluefish Pharmaceuticals ABPA1436/041/002

Main Information

Trade NameSunitinib Bluefish 25 mg hard capsules
Active SubstancesSunitinib
Dosage FormCapsule, hard
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/041/002

Group Information

ATC CodeL01EX01 sunitinib

Status

License statusAuthorised
Licence Issued17/02/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back